Health care spending per person increased to $5,641 in 2017
(HealthDay)—In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Feb 13, 2019
0
1
(HealthDay)—In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Feb 13, 2019
0
1
(HealthDay)—National health care spending slowed in 2017, according to a report published online Dec. 6 in Health Affairs.
Dec 12, 2018
0
4
(HealthDay)—Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines, a new study shows.
Nov 16, 2018
0
0
Government spending for the catastrophic drug program in Ontario rose 700 per cent between 2000 and 2016, during which there was a three-fold increase in the use of this plan, a new study has found.
Mar 26, 2018
0
1
(HealthDay)—Americans spent more on health care in 2016, even though their use of health care did not increase, and rising costs are the reason why, a new report shows.
Jan 23, 2018
0
6
Medicare spent more than $1 billion over a five-year period on a high-priced drug that has not been proven more effective for a collection of inflammatory conditions than much less expensive corticosteroids, research by the ...
Sep 11, 2017
0
0
Although topical steroids are among the most commonly prescribed medications by dermatologists, there are limited data on spending and use for this class of drugs. In a new study led by investigators at Brigham and Women's ...
Apr 29, 2017
0
8
Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.
Sep 9, 2016
0
4
High prescription drug prices are attributable to several causes, including the approach the U.S. has taken to granting government-protected monopolies to drug manufacturers, and the restriction of price negotiation at a ...
Aug 23, 2016
0
0
Although the recently FDA approved cholesterol-lowering drugs, PCSK9 inhibitors, could substantially reduce heart attacks, strokes, and cardiovascular deaths, they would not be cost-effective for use in patients with heterozygous ...
Aug 16, 2016
0
1